Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the efficacy of lapaquistat acetate, once daily
(QD), taken with ezetimibe on cholesterol levels in subjects with primary dyslipidemia